Elo Mutual Pension Insurance Co Buys New Stake in STERIS plc (NYSE:STE)

Elo Mutual Pension Insurance Co acquired a new stake in shares of STERIS plc (NYSE:STE - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 10,235 shares of the medical equipment provider's stock, valued at approximately $2,104,000.

Several other large investors have also bought and sold shares of STE. Franklin Resources Inc. boosted its position in shares of STERIS by 171.2% during the third quarter. Franklin Resources Inc. now owns 838,569 shares of the medical equipment provider's stock valued at $191,370,000 after buying an additional 529,308 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. boosted its holdings in shares of STERIS by 30.8% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 10,970 shares of the medical equipment provider's stock valued at $2,275,000 after acquiring an additional 2,583 shares during the last quarter. Wilmington Savings Fund Society FSB purchased a new stake in shares of STERIS during the 3rd quarter valued at about $9,949,000. Public Sector Pension Investment Board raised its holdings in shares of STERIS by 13.2% during the third quarter. Public Sector Pension Investment Board now owns 4,283 shares of the medical equipment provider's stock valued at $1,039,000 after purchasing an additional 500 shares during the last quarter. Finally, Merit Financial Group LLC bought a new position in STERIS during the fourth quarter valued at approximately $260,000. 94.69% of the stock is owned by hedge funds and other institutional investors.

STERIS Trading Down 2.1 %

Shares of NYSE:STE traded down $4.82 during trading hours on Thursday, hitting $222.75. 102,682 shares of the company's stock traded hands, compared to its average volume of 528,362. The business has a fifty day moving average price of $223.22 and a 200-day moving average price of $220.93. The firm has a market capitalization of $21.89 billion, a P/E ratio of 47.29 and a beta of 0.92. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.13 and a quick ratio of 1.40. STERIS plc has a 1 year low of $197.82 and a 1 year high of $248.24.

Remove Ads

STERIS (NYSE:STE - Get Free Report) last issued its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 EPS for the quarter, missing analysts' consensus estimates of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. Equities analysts expect that STERIS plc will post 9.08 earnings per share for the current year.

STERIS Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, March 21st. Stockholders of record on Thursday, February 20th were issued a $0.57 dividend. The ex-dividend date of this dividend was Thursday, February 20th. This represents a $2.28 annualized dividend and a dividend yield of 1.02%. STERIS's dividend payout ratio is currently 48.41%.

Analyst Ratings Changes

STE has been the subject of a number of research reports. JMP Securities reiterated a "market outperform" rating and set a $265.00 price objective on shares of STERIS in a research report on Thursday, February 6th. Piper Sandler upped their target price on shares of STERIS from $260.00 to $265.00 and gave the stock an "overweight" rating in a research report on Monday, February 3rd. Finally, Stephens reissued an "overweight" rating and issued a $240.00 target price on shares of STERIS in a report on Thursday, February 6th. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $258.75.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.